Nine-month, all-oral regimens for rifampin-resistant tuberculosis
Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez, Maelenn Gouillou, Amanzhan Abubakirov, Elisabeth Baudin, Elmira Berikova, Catherine Berry, Maryline Bonnet, Matteo Cellamare, Vijay Chavan, Vivian Cox, Zhanna Dakenova, Bouke Catherine de Jong, Gabriella Ferlazzo, Aydarkhan Karabayev, Ohanna Kirakosyan, Nana Kiria, Mikanda Kunda, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Ilaria Motta, Sergio Mucching-Toscano, Hebah Mushtaque, Payam Nahid, Lawrence Oyewusi, Samiran Panda, Sandip Patil, Patrick Phillips, Jimena Ruiz, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J. Seung, Eduardo Ticona, Lorenzo Trippa, Dante Vargas, Sean Wasserman, Michael L. Rich, Francis Varaine, Carole D. Mitnick
doi: https://doi.org/10.1101/2024.01.29.24301679
Lorenzo Guglielmetti
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Uzma Khan
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Gustavo E. Velásquez
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Maelenn Gouillou
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Amanzhan Abubakirov
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Elisabeth Baudin
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Elmira Berikova
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Catherine Berry
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Maryline Bonnet
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Matteo Cellamare
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Vijay Chavan
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Vivian Cox
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Zhanna Dakenova
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Bouke Catherine de Jong
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Gabriella Ferlazzo
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Aydarkhan Karabayev
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Ohanna Kirakosyan
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Nana Kiria
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Mikanda Kunda
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Nathalie Lachenal
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Leonid Lecca
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Helen McIlleron
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Ilaria Motta
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Sergio Mucching-Toscano
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Hebah Mushtaque
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Payam Nahid
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Lawrence Oyewusi
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Samiran Panda
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Sandip Patil
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Patrick Phillips
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Jimena Ruiz
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Naseem Salahuddin
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Epifanio Sanchez-Garavito
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Kwonjune J. Seung
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Eduardo Ticona
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Lorenzo Trippa
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Dante Vargas
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Sean Wasserman
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Michael L. Rich
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Francis Varaine
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Carole D. Mitnick
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Abstract
Background After a history of poor treatments for rifampin-resistant tuberculosis (RR-TB), recent advances have resulted in shorter, more effective treatments. However, they are not available to everyone and have shortcomings, requiring additional treatment options.
Methods endTB is an international, open-label, Phase 3 non-inferiority, randomized, controlled clinical trial to compare five 9-month all-oral regimens including bedaquiline (B), delamanid (D), linezolid (L), levofloxacin (Lfx) or moxifloxacin (M), clofazimine (C) and pyrazinamide (Z), to the standard (control) for treatment of fluoroquinolone-susceptible RR-TB. Participants were randomized to 9BLMZ, 9BCLLfxZ, 9BDLLfxZ, 9DCLLfxZ, 9DCMZ and control using Bayesian response-adaptive randomization. The primary outcome was favorable outcome at week 73 defined by two negative sputum culture results or by favorable bacteriologic, clinical and radiologic evolution. The non-inferiority margin was 12 percentage points.
Results Of 754 randomized patients, 696 and 559 were included in the modified intention to treat (mITT) and per-protocol (PP) analyses, respectively. In mITT, the control had 80.7% favorable outcomes. Regimens 9BCLLfxZ [adjusted risk difference (aRD): 9.5% (95% confidence interval (CI), 0.4 to 18.6)], 9BLMZ [aRD: 8.8% (95%CI, −0.6 to 18.2)], and 9BDLLfxZ [3.9% (95%CI, −5.8 to 13.6)] were non-inferior in mITT and in PP. The proportion of participants experiencing grade 3 or higher adverse events was similar across the regimens. Grade 3 or higher hepatotoxicity occurred in 11.7% of the experimental regimens overall and in 7.1% of the control.
Conclusions The endTB trial increases treatment options for RR-TB with three shortened, all-oral regimens that were non-inferior to a current well-performing standard of care.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02754765
Funding Statement
This study was funded by Unitaid.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committees/IRBs of Medecins Sans Frontieres, Harvard Medical School, Institute of Tropical Medicine Antwerp, Interactive Research and Development, and each participating site, gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted January 29, 2024.
Nine-month, all-oral regimens for rifampin-resistant tuberculosis
Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez, Maelenn Gouillou, Amanzhan Abubakirov, Elisabeth Baudin, Elmira Berikova, Catherine Berry, Maryline Bonnet, Matteo Cellamare, Vijay Chavan, Vivian Cox, Zhanna Dakenova, Bouke Catherine de Jong, Gabriella Ferlazzo, Aydarkhan Karabayev, Ohanna Kirakosyan, Nana Kiria, Mikanda Kunda, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Ilaria Motta, Sergio Mucching-Toscano, Hebah Mushtaque, Payam Nahid, Lawrence Oyewusi, Samiran Panda, Sandip Patil, Patrick Phillips, Jimena Ruiz, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J. Seung, Eduardo Ticona, Lorenzo Trippa, Dante Vargas, Sean Wasserman, Michael L. Rich, Francis Varaine, Carole D. Mitnick
medRxiv 2024.01.29.24301679; doi: https://doi.org/10.1101/2024.01.29.24301679
Nine-month, all-oral regimens for rifampin-resistant tuberculosis
Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez, Maelenn Gouillou, Amanzhan Abubakirov, Elisabeth Baudin, Elmira Berikova, Catherine Berry, Maryline Bonnet, Matteo Cellamare, Vijay Chavan, Vivian Cox, Zhanna Dakenova, Bouke Catherine de Jong, Gabriella Ferlazzo, Aydarkhan Karabayev, Ohanna Kirakosyan, Nana Kiria, Mikanda Kunda, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Ilaria Motta, Sergio Mucching-Toscano, Hebah Mushtaque, Payam Nahid, Lawrence Oyewusi, Samiran Panda, Sandip Patil, Patrick Phillips, Jimena Ruiz, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J. Seung, Eduardo Ticona, Lorenzo Trippa, Dante Vargas, Sean Wasserman, Michael L. Rich, Francis Varaine, Carole D. Mitnick
medRxiv 2024.01.29.24301679; doi: https://doi.org/10.1101/2024.01.29.24301679
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)